SFTPC (Surfactant protein C) variants and mutations
SFTPC (also known as Surfactant protein C) is a human protein-coding gene encoding a surfactant protein C protein. It contributes to pulmonary surfactant organization and is produced specifically by alveolar type II cells. Dominant pathogenic variants can cause interstitial lung disease across infancy and adulthood, often through protein misfolding and toxic cellular stress. This analysis covers 420 SFTPC variants and mutations. Of these, 78% have computational variant effect predictions. Disease context includes Congenital pulmonary alveolar proteinosis, surfactant metabolism dysfunction, pulmonary, 2, and chronic respiratory distress with surfactant metabolism deficiency. Example SFTPC variants include V3M, V3V, and G4S.
Variant analysis overview
- Gene: SFTPC
- Protein: Surfactant protein C
- UniProt accession: P11686
- Organism: Homo sapiens
- Variants analyzed: 420
- Variant scope: all variants
- Completed: 2026-08-21
Variant and mutation evidence
- Variant composition: 255 unspecified-consequence records; 80 synonymous variants; 65 missense variants; 15 frameshift variants; 2 splice-region variants; 2 stop-gained variants; 1 in-frame insertions; 3 in-frame deletions; 2 stop lost
- Prediction scores: 327 variants have prediction scores (78% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: Congenital pulmonary alveolar proteinosis, surfactant metabolism dysfunction, pulmonary, 2, chronic respiratory distress with surfactant metabolism deficiency, hereditary pulmonary alveolar proteinosis, interstitial lung disease, idiopathic pulmonary fibrosis, newborn respiratory distress syndrome, pulmonary alveolar proteinosis, hereditary disease, pulmonary fibrosis, Neonatal acute respiratory distress with surfactant metabolism deficiency, surfactant metabolism dysfunction, pulmonary, 1.
Protein structure and variant hotspots
- Protein features: 1 domains.
- Structural context: 209 variants have structural context.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Notable SFTPC variants
Examples include V3M, V3V, G4S, S5G, S5I, S5S, K6Q, K6K. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- V3M (p.Val3Met), TOPMed rs1827735137, CADD 8.43, PolyPhen-2 0.05
- V3V (p.Val3Val), rs1225897786, gnomAD 8-22161837-G-A, CADD 6.18
- G4S (p.Gly4Ser), rs201896861, ClinGen CA4663850, cosmic curated COSV59346, ClinVar RCV001248771, CADD 15.50, PolyPhen-2 0.17, Uncertain significance, Surfactant metabolism dysfunction, pulmonary, 1; not provided
- S5G (p.Ser5Gly), gnomAD rs1348077478, CADD 25.60, PolyPhen-2 0.73
- S5I (p.Ser5Ile), gnomAD 8-22161842-G-T, CADD 25.90, PolyPhen-2 0.88
- S5S (p.Ser5Ser), gnomAD 8-22161843-C-T, CADD 13.90
- K6Q (p.Lys6Gln), gnomAD 8-22161844-A-C, CADD 26.20, PolyPhen-2 1.00
- K6K (p.Lys6Lys), rs1238864623, gnomAD 8-22161846-A-G, CADD 10.50
- E7G (p.Glu7Gly), TOPMed rs1827736332
- V8F (p.Val8Phe), TOPMed rs1489591822, gnomAD rs1489591822, CADD 25.00, PolyPhen-2 0.78, Uncertain significance, Hereditary pulmonary alveolar proteinosis
- V8L (p.Val8Leu), TOPMed rs1489591822, gnomAD rs1489591822, CADD 21.50, Uncertain significance, Hereditary pulmonary alveolar proteinosis
- V8A (p.Val8Ala), gnomAD 8-22161851-T-C, CADD 18.30, PolyPhen-2 0.01
- V8V (p.Val8Val), rs144603526, gnomAD 8-22161852-C-G, CADD 8.22
- L9P (p.Leu9Pro), Ensembl rs11552815
- L9* (p.Leu9Ter), rs1191931272, gnomAD 8-22161851-TC-T, CADD 24.00
- L9L (p.Leu9Leu), rs1827737458, gnomAD 8-22161855-G-T, CADD 12.20
- M10I (p.Met10Ile), TOPMed rs1827737974, CADD 22.20, PolyPhen-2 0.01
- M10L (p.Met10Leu), ExAC rs773026639, gnomAD rs773026639, CADD 22.40, PolyPhen-2 0.00
- M10R (p.Met10Arg), TOPMed rs1827737800, CADD 28.90, PolyPhen-2 0.60
- E11G (p.Glu11Gly), gnomAD 8-22161860-A-G, CADD 32.00, PolyPhen-2 0.86
- E11E (p.Glu11Glu), rs1827738151, gnomAD 8-22161861-G-A, CADD 10.50
- S12N (p.Ser12Asn), TOPMed rs1827738336, gnomAD rs1827738336, CADD 20.60, PolyPhen-2 0.01
- S12S (p.Ser12Ser), rs369413166, gnomAD 8-22161864-C-T, CADD 8.09
- P13L (p.Pro13Leu), rs1827738719, ClinGen CA370536602, NCI-TCGA Cosmic COSV1001, cosmic curated COSV10011, CADD 25.50, PolyPhen-2 1.00, Uncertain significance, SFTPC-related disorder
- P13P (p.Pro13Pro), rs532360636, gnomAD 8-22161867-G-A, CADD 4.40
- P14L (p.Pro14Leu), rs2131811698, ClinGen CA370536608, ClinVar RCV004455849, Ensembl rs2131811698, CADD 25.70, PolyPhen-2 1.00, Uncertain significance, Hereditary pulmonary alveolar proteinosis
- P14S (p.Pro14Ser), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- P14P (p.Pro14Pro), rs199905878, gnomAD 8-22161870-G-A, CADD 21.20
- D15E (p.Asp15Glu), gnomAD rs1193793494, CADD 19.80, PolyPhen-2 1.00
- D15N (p.Asp15Asn), ESP rs376399274, ExAC rs376399274, gnomAD rs376399274, CADD 27.70, PolyPhen-2 1.00
- S17F (p.Ser17Phe), NCI-TCGA Cosmic COSV5934, cosmic curated COSV59345, CADD 24.50, PolyPhen-2 0.90, Variant assessed as somatic; moderate impact.
- S17Y (p.Ser17Tyr), Ensembl rs2131814661, CADD 24.00, PolyPhen-2 0.95
- S17P (p.Ser17Pro), gnomAD 8-22162580-T-C, CADD 21.40, PolyPhen-2 0.86
- S17S (p.Ser17Ser), rs752201591, gnomAD 8-22162582-C-T, CADD 0.18
- A18T (p.Ala18Thr), ExAC rs755609275, gnomAD rs755609275, CADD 21.90, PolyPhen-2 0.02, Likely benign, Hereditary pulmonary alveolar proteinosis
- A19V (p.Ala19Val), TOPMed rs979006596, gnomAD rs979006596, CADD 13.60, PolyPhen-2 0.01
- P20S (p.Pro20Ser), ExAC rs777698296, gnomAD rs777698296, CADD 16.40, PolyPhen-2 0.35
- P20L (p.Pro20Leu), gnomAD 8-22162590-C-T, CADD 23.40, PolyPhen-2 0.91
- P20P (p.Pro20Pro), gnomAD 8-22162591-C-A, CADD 5.33
- R21P (p.Arg21Pro), ESP rs371321234, ExAC rs371321234, TOPMed rs371321234, gnomAD rs371321234, CADD 24.90, PolyPhen-2 0.74, Uncertain significance
- R21Q (p.Arg21Gln), rs371321234, ClinGen CA4663889, ClinVar RCV002368782, ESP rs371321234, CADD 22.00, PolyPhen-2 0.01, Benign, Hereditary pulmonary alveolar proteinosis
- R21W (p.Arg21Trp), cosmic curated COSV59345, gnomAD rs1189313783, CADD 24.20, PolyPhen-2 0.83
- G22D (p.Gly22Asp), ExAC rs778672867, CADD 21.10, PolyPhen-2 0.78
- G22S (p.Gly22Ser), gnomAD 8-22162595-G-A, CADD 21.10, PolyPhen-2 0.17
- G22G (p.Gly22Gly), gnomAD 8-22162597-C-T, CADD 12.20
- R23* (p.Arg23Ter), ESP rs375581850, ExAC rs375581850, TOPMed rs375581850, gnomAD rs375581850, CADD 44.00
- R23L (p.Arg23Leu), 1000Genomes rs75902455, ExAC rs75902455, TOPMed rs75902455, gnomAD rs75902455, CADD 23.50, PolyPhen-2 0.63, Benign
- R23Q (p.Arg23Gln), rs75902455, ClinGen CA4663893, cosmic curated COSV59346, ClinVar RCV001160162, CADD 21.80, PolyPhen-2 0.03, Benign/Likely benign, Interstitial lung disease 2; not provided; Hereditary pulmonary alveolar protein
- R23D (p.Arg23Asp), rs1563221226, gnomAD 8-22162596-GC-G, CADD 24.60
- R23R (p.Arg23Arg), rs1410152662, gnomAD 8-22162600-A-T, CADD 8.72
- F24S (p.Phe24Ser), Ensembl rs1053466380, CADD 25.70, PolyPhen-2 0.80
- G25D (p.Gly25Asp), TOPMed rs1827790324, CADD 21.30, PolyPhen-2 0.52
- G25S (p.Gly25Ser), ExAC rs768626980, gnomAD rs768626980, CADD 13.50, PolyPhen-2 0.26
- G25G (p.Gly25Gly), gnomAD 8-22162606-C-T, CADD 12.50
- I26T (p.Ile26Thr), ExAC rs777139008, gnomAD rs777139008, CADD 26.60, PolyPhen-2 0.81
- I26V (p.Ile26Val), ESP rs368656172
- P27L (p.Pro27Leu), ExAC rs762396958, gnomAD rs762396958, CADD 26.80, PolyPhen-2 1.00
- P27S (p.Pro27Ser), NCI-TCGA Cosmic COSV5934, cosmic curated COSV59346, CADD 25.30, PolyPhen-2 1.00, Variant assessed as somatic; moderate impact.
- C28S (p.Cys28Ser), TOPMed rs1458422311, gnomAD rs1458422311, CADD 24.80
- C28Y (p.Cys28Tyr), rs1458422311, ClinGen CA370536693, ClinVar RCV002509792, NCI-TCGA TCGA novel, CADD 26.80, PolyPhen-2 1.00, Likely risk allele, Pulmonary fibrosis
- C28* (p.Cys28Ter), gnomAD 8-22162615-C-A, CADD 37.00
- C28C (p.Cys28Cys), gnomAD 8-22162615-C-T, CADD 12.90
- C29C (p.Cys29Cys), rs770491816, gnomAD 8-22162618-C-T, CADD 10.00
- P30S (p.Pro30Ser), rs2538940967, ClinGen CA370536708, ClinVar RCV002376051, NCI-TCGA TCGA novel, Uncertain significance, Hereditary pulmonary alveolar proteinosis
- P30T (p.Pro30Thr), gnomAD 8-22162619-C-A, CADD 24.60, PolyPhen-2 1.00
- P30L (p.Pro30Leu), gnomAD 8-22162620-C-T, CADD 23.20, PolyPhen-2 1.00
- V31A (p.Val31Ala), TOPMed rs1443130935, CADD 10.90, PolyPhen-2 0.14
- V31G (p.Val31Gly), TOPMed rs1443130935, CADD 14.50, PolyPhen-2 0.01
- V31L (p.Val31Leu), Ensembl rs1827791481
- V31V (p.Val31Val), rs773682315, gnomAD 8-22162624-G-A, CADD 8.86
- H32L (p.His32Leu), rs2538941008, ClinGen CA370536730, ClinVar RCV002298223, Uncertain significance, not provided
- H32Y (p.His32Tyr), rs192391655, ClinGen CA4663900, ClinVar RCV002374126, 1000Genomes rs192391655, CADD 14.70, PolyPhen-2 0.47, Benign, Hereditary pulmonary alveolar proteinosis
- H32N (p.His32Asn), gnomAD 8-22162625-C-A, CADD 5.13, PolyPhen-2 0.00
- H32H (p.His32His), rs767156369, gnomAD 8-22162627-C-T, CADD 6.63
- K34N (p.Lys34Asn), gnomAD 8-22162633-A-T, CADD 23.50, PolyPhen-2 1.00
- R35C (p.Arg35Cys), rs199854076, cosmic curated COSV59345, 1000Genomes rs199854076, ESP rs199854076, CADD 25.50, PolyPhen-2 1.00, Variant assessed as somatic; moderate impact.
- R35H (p.Arg35His), TOPMed rs1200065902, gnomAD rs1200065902, CADD 28.30, PolyPhen-2 1.00, Uncertain significance, SFTPC-related disorder
- R35R (p.Arg35Arg), rs1178465970, gnomAD 8-22162636-C-T, CADD 12.40
- L36L (p.Leu36Leu), gnomAD 8-22162639-T-G, CADD 10.20
- L37P (p.Leu37Pro), TOPMed rs1479189925, gnomAD rs1479189925, CADD 28.60
- I38V (p.Ile38Val), TOPMed rs934921398, gnomAD rs934921398, CADD 20.50, PolyPhen-2 0.03
- I38I (p.Ile38Ile), rs375940265, gnomAD 8-22162645-C-T, CADD 10.50
- V39L (p.Val39Leu), rs183533911, ClinGen CA4663906, cosmic curated COSV59346, ClinVar RCV000315399, CADD 21.10, PolyPhen-2 0.03, Uncertain significance, not provided
- V39M (p.Val39Met), rs183533911, ClinGen CA4663907, cosmic curated COSV59345, ClinVar RCV000224142, CADD 22.50, PolyPhen-2 0.66, Uncertain significance, Surfactant metabolism dysfunction, pulmonary, 2; not provided
- V39W (p.Val39Trp), rs1827793776, gnomAD 8-22162645-CG-C, CADD 24.10
- V39V (p.Val39Val), gnomAD 8-22162648-G-C, CADD 7.56
- V40A (p.Val40Ala), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- V41L (p.Val41Leu), gnomAD 8-22162652-G-C, CADD 25.60, PolyPhen-2 0.99
- V41V (p.Val41Val), gnomAD 8-22162654-G-T, CADD 9.69
- V42M (p.Val42Met), TOPMed rs1827794323
- p.Val42 Val44del, rs752666425, gnomAD 8-22162645-CGTGGT, CADD 20.40
- V42V (p.Val42Val), gnomAD 8-22162657-G-T, CADD 8.62
- V43A (p.Val43Ala), TOPMed rs1369790485
- V43L (p.Val43Leu), gnomAD rs1827794474, CADD 22.00, PolyPhen-2 0.38
- V43M (p.Val43Met), gnomAD 8-22162658-G-A, CADD 25.60, PolyPhen-2 0.93
- V44I (p.Val44Ile), ExAC rs757152791, gnomAD rs757152791, CADD 25.50, PolyPhen-2 0.99
- p.Val44dup, rs752666425, gnomAD 8-22162645-C-CGTG, CADD 15.80
- V44del (p.Val44del), rs752666425, gnomAD 8-22162645-CGTG-C, CADD 19.70
- V44F (p.Val44Phe), gnomAD 8-22162661-G-T, CADD 26.50, PolyPhen-2 1.00
- V44L (p.Val44Leu), gnomAD 8-22162661-G-C, CADD 24.20, PolyPhen-2 0.99
- L45P (p.Leu45Pro), rs948413532, ClinGen CA173482989, ClinVar RCV003320434, ClinVar RCV005402027, CADD 25.70, PolyPhen-2 1.00, Uncertain significance, not provided; Surfactant metabolism dysfunction, pulmonary, 2
- L45F (p.Leu45Phe), gnomAD 8-22162664-C-T, CADD 24.10, PolyPhen-2 1.00
- L45L (p.Leu45Leu), rs1211620816, gnomAD 8-22162666-C-T, CADD 0.23
- I46T (p.Ile46Thr), TOPMed rs1827795468
- I46V (p.Ile46Val), Ensembl rs2131815144, CADD 5.30, PolyPhen-2 0.00
- I46N (p.Ile46Asn), gnomAD 8-22162668-T-A, CADD 22.50, PolyPhen-2 0.45
- I46I (p.Ile46Ile), rs548523225, gnomAD 8-22162669-C-T, CADD 0.35
- V47A (p.Val47Ala), NCI-TCGA TCGA novel, CADD 24.50, PolyPhen-2 0.99, Variant assessed as somatic; moderate impact.
- V47I (p.Val47Ile), rs750172249, NCI-TCGA Cosmic COSV5934, cosmic curated COSV59346, ExAC rs750172249, CADD 23.90, PolyPhen-2 0.99, Variant assessed as somatic; moderate impact.
- V47V (p.Val47Val), rs764818190, gnomAD 8-22162672-C-T, CADD 1.08
- V48L (p.Val48Leu), 1000Genomes rs566914013, ExAC rs566914013, TOPMed rs566914013, gnomAD rs566914013, CADD 23.00, PolyPhen-2 1.00, Likely benign
- V48M (p.Val48Met), rs566914013, ClinGen CA4663912, ClinVar RCV000306866, ClinVar RCV000407976, CADD 24.70, PolyPhen-2 1.00, Conflicting interpretations, Surfactant metabolism dysfunction, pulmonary, 2; Interstitial lung disease 2; He
- V48V (p.Val48Val), rs747210099, gnomAD 8-22162675-G-A, CADD 10.10
- V49M (p.Val49Met), NCI-TCGA TCGA novel, CADD 25.60, PolyPhen-2 1.00, Likely risk allele, Pulmonary fibrosis
- I50M (p.Ile50Met), rs768981838, ClinGen CA4663914, ClinVar RCV003136636, ClinVar RCV005744631, CADD 22.40, PolyPhen-2 0.93, Uncertain significance, Hereditary pulmonary alveolar proteinosis; Surfactant metabolism dysfunction, pu
- I50T (p.Ile50Thr), gnomAD rs1172658254, CADD 26.20, PolyPhen-2 0.74
- I50I (p.Ile50Ile), rs768981838, gnomAD 8-22162681-T-C, CADD 8.49
- V51V (p.Val51Val), rs781417860, gnomAD 8-22162684-G-A, CADD 1.51
- G52R (p.Gly52Arg), gnomAD 8-22162685-G-A, CADD 27.60, PolyPhen-2 1.00
- G52E (p.Gly52Glu), gnomAD 8-22162686-G-A, CADD 27.00, PolyPhen-2 1.00
- G52G (p.Gly52Gly), rs1312942349, gnomAD 8-22162687-A-G, CADD 11.60
- A53D (p.Ala53Asp), gnomAD rs1380423232, CADD 25.50, PolyPhen-2 1.00
- A53T (p.Ala53Thr), rs200039720, ClinGen CA4663916, ClinVar RCV001163545, ClinVar RCV001163546, CADD 24.30, PolyPhen-2 1.00, Conflicting interpretations, not provided; Interstitial lung disease 2; Surfactant metabolism dysfunction, pu
- A53V (p.Ala53Val), gnomAD 8-22162689-C-T, CADD 23.10, PolyPhen-2 1.00
- A53A (p.Ala53Ala), rs376182452, gnomAD 8-22162690-C-T, CADD 12.50
- L54L (p.Leu54Leu), rs1285055943, gnomAD 8-22162691-C-T, CADD 11.60
- L55F (p.Leu55Phe), rs1563221666, ClinGen CA370536923, ClinVar RCV003411688, ClinVar RCV005251196, AlphaMissense 0.69, MetaLR 0.88, Likely pathogenic, SFTPC-related disorder; not provided
- L55L (p.Leu55Leu), rs1827798275, gnomAD 8-22162696-C-G, CADD 7.86
- M56I (p.Met56Ile), gnomAD rs1232177240, CADD 24.10, PolyPhen-2 0.98
- M56L (p.Met56Leu), TOPMed rs1320098621, gnomAD rs1320098621, CADD 23.30, PolyPhen-2 0.94
- M56T (p.Met56Thr), TOPMed rs1047415320, gnomAD rs1047415320, CADD 25.80, PolyPhen-2 0.98
- M56V (p.Met56Val), TOPMed rs1320098621, gnomAD rs1320098621, CADD 24.80, PolyPhen-2 0.98
- G57C (p.Gly57Cys), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- G57S (p.Gly57Ser), cosmic curated COSV59345, ESP rs369239281, ExAC rs369239281, TOPMed rs369239281, CADD 26.00, PolyPhen-2 1.00, Uncertain significance, not provided
- G57D (p.Gly57Asp), gnomAD 8-22162701-G-A, CADD 25.60, PolyPhen-2 1.00
- L58I (p.Leu58Ile), gnomAD 8-22162703-C-A, CADD 25.40, PolyPhen-2 1.00
- L58P (p.Leu58Pro), gnomAD 8-22162704-T-C, CADD 29.30, PolyPhen-2 1.00
- L58L (p.Leu58Leu), rs1159277684, gnomAD 8-22162705-C-T, CADD 8.08
- H59R (p.His59Arg), rs201567623, ClinGen CA4663918, ClinVar RCV000271807, ClinVar RCV000366166, CADD 23.80, PolyPhen-2 1.00, Conflicting interpretations, Surfactant metabolism dysfunction, pulmonary, 2; Interstitial lung disease 2; He
- H59H (p.His59His), gnomAD 8-22162708-C-T, CADD 11.40
- M60T (p.Met60Thr), gnomAD 8-22162710-T-C, CADD 25.70, PolyPhen-2 0.30
- M60I (p.Met60Ile), gnomAD 8-22162711-G-A, CADD 21.50, PolyPhen-2 0.08
- S61G (p.Ser61Gly), rs2538941481, ClinGen CA370536962, ClinVar RCV002410321, Uncertain significance, Hereditary pulmonary alveolar proteinosis
- S61S (p.Ser61Ser), rs1827799478, gnomAD 8-22162714-C-T, CADD 11.80
- Q62K (p.Gln62Lys), gnomAD 8-22162715-C-A, CADD 25.50, PolyPhen-2 0.99
- Q62Q (p.Gln62Gln), gnomAD 8-22162717-G-A, CADD 9.68
- K63E (p.Lys63Glu), rs2538941498, ClinGen CA370536980, ClinVar RCV002283993, Uncertain significance, Surfactant metabolism dysfunction, pulmonary, 2
- K63N (p.Lys63Asn), gnomAD 8-22162717-GA-G, CADD 32.00
- H64Q (p.His64Gln), rs2131815446, ClinGen CA370536993, ClinVar RCV002276254, Ensembl rs2131815446, AlphaMissense 0.89, MetaLR 0.86, Uncertain significance, not provided
- T65A (p.Thr65Ala), TOPMed rs1827799857
- T65M (p.Thr65Met), rs547252810, ExAC rs547252810, TOPMed rs547252810, gnomAD rs547252810, CADD 26.50, PolyPhen-2 1.00, Variant assessed as somatic; moderate impact.
- T65G (p.Thr65Gly), rs1405405553, gnomAD 8-22162719-AAC-A, CADD 32.00
- T65T (p.Thr65Thr), rs188074517, gnomAD 8-22162726-G-A, CADD 1.11
- E66K (p.Glu66Lys), rs121917836, ClinGen CA210544, cosmic curated COSV59346, ClinVar RCV000014100, AlphaMissense 0.61, MetaLR 0.88, Pathogenic, Surfactant metabolism dysfunction, pulmonary, 2
- M67I (p.Met67Ile), NCI-TCGA Cosmic COSV5934, cosmic curated COSV59345, Variant assessed as somatic; moderate impact.
- M67T (p.Met67Thr), rs2538941541, ClinGen CA370537010, ClinVar RCV003443576, CADD 17.60, PolyPhen-2 0.98, Uncertain significance, not provided
- V68F (p.Val68Phe), rs2131816806, ClinGen CA370537165, ClinVar RCV001906643, ClinVar RCV002423012, AlphaMissense 0.64, MetaLR 0.88, Conflicting interpretations, not provided; Hereditary pulmonary alveolar proteinosis
- V68I (p.Val68Ile), gnomAD 8-22163080-G-A, CADD 23.20, PolyPhen-2 0.14
- V68V (p.Val68Val), rs1253679703, gnomAD 8-22163082-T-C, CADD 8.82
- L69L (p.Leu69Leu), rs900601110, gnomAD 8-22163083-C-T, CADD 9.28
- E70G (p.Glu70Gly), rs2538943124, ClinVar RCV004590503, CADD 29.10, PolyPhen-2 1.00, Uncertain significance, not provided
- M71I (p.Met71Ile), TOPMed rs1827825083, CADD 24.30, PolyPhen-2 0.98
- M71T (p.Met71Thr), TOPMed rs1827824904, CADD 24.90, PolyPhen-2 0.99
- M71V (p.Met71Val), Ensembl rs1827824745
- S72S (p.Ser72Ser), gnomAD 8-22163094-C-T, CADD 11.70
- I73N (p.Ile73Asn), ExAC rs121917834, TOPMed rs121917834, gnomAD rs121917834, CADD 26.10, PolyPhen-2 0.87, Pathogenic, in SMDP2
- I73T (p.Ile73Thr), rs121917834, ClinGen CA210536, ClinVar RCV000014095, ClinVar RCV000731190, CADD 23.40, PolyPhen-2 0.59, Pathogenic/Likely pathogenic, Hereditary pulmonary alveolar proteinosis; not provided; Surfactant metabolism d
- I73V (p.Ile73Val), gnomAD 8-22163095-A-G, CADD 22.00, PolyPhen-2 0.22
- I73I (p.Ile73Ile), gnomAD 8-22163097-T-C, CADD 2.83
- A75V (p.Ala75Val), rs1000316822, NCI-TCGA Cosmic COSV5934, cosmic curated COSV59345, TOPMed rs1000316822, CADD 23.40, PolyPhen-2 0.78, Variant assessed as somatic; moderate impact.
- A75A (p.Ala75Ala), rs369210212, gnomAD 8-22163103-G-A, CADD 0.18
- P76L (p.Pro76Leu), cosmic curated COSV10511, ExAC rs201454136, TOPMed rs201454136, gnomAD rs201454136, CADD 12.20, PolyPhen-2 0.07
- P76Q (p.Pro76Gln), ExAC rs201454136, TOPMed rs201454136, gnomAD rs201454136, CADD 16.00, PolyPhen-2 0.96
- P76S (p.Pro76Ser), gnomAD 8-22163104-C-T, CADD 6.95, PolyPhen-2 0.10
- P76P (p.Pro76Pro), gnomAD 8-22163106-G-T, CADD 0.05
- E77G (p.Glu77Gly), TOPMed rs1827826905, gnomAD rs1827826905, CADD 23.40, PolyPhen-2 0.91
- E77K (p.Glu77Lys), ExAC rs772841457, TOPMed rs772841457, gnomAD rs772841457, CADD 25.20, PolyPhen-2 0.86
- A78D (p.Ala78Asp), 1000Genomes rs2131816947, CADD 23.50
- A78G (p.Ala78Gly), NCI-TCGA Cosmic COSV1001, cosmic curated COSV10010, CADD 16.90, PolyPhen-2 0.18, Variant assessed as somatic; moderate impact.
- A78P (p.Ala78Pro), Ensembl rs1827827082
Public SFTPC analysis runs
- SFTPC analysis run — SFTPC (420 variants) — completed 2026-08-21